Biogen Agrees to Pay $900M to Resolve Kickback Claims September 27, 2022 By Erik Larson A Biogen Inc. whistle-blower will collect almost $250 million for bringing to light a kickback scheme the company agreed to...
EU Seeks Review of GMO Rules for Gene-Edited Crops April 30, 2021 By Philip Blenkinsop BRUSSELS — The European Commission launched a review of EU rules on genetically modified organisms (GMOs) on Thursday, opening the...
COVID-Sniffing Robots Promise Fast Testing Alternative October 2, 2020 By Kristen V. Brown A biotechnology startup called Koniku is trying to develop robots that could sniff out Covid-19 infections faster than conventional testing....
U.S. Completes Overhaul of Biotech Farm Product Regulations May 18, 2020 By P.J. Huffstutter The U.S. Department of Agriculture announced on Thursday a rule that will simplify or waive agency reviews of certain biotech...
Court Ruling Against ‘Law of Nature’ Patent Riles Biotech February 7, 2019 By Susan Decker and Malathi Nayak A way to diagnose a severe neurological disorder can’t be patented as it covers a law of nature, a U.S....
ACE Launches Enhanced Clinical Trials Liability Cover for UK Companies March 23, 2015 ACE Group has launched an enhanced clinical trials liability proposition for UK companies, which provides life science companies with specialist...
ACE Expands Life Sciences Coverage through Wholesale Division July 1, 2014 ACE Group has expanded its suite of products developed to address the needs of U.S.-based life sciences companies through its...
ACE Enhances Life Sciences Coverage Offerings April 24, 2014 The ACE Medical Risk Group has enhanced its life sciences capabilities to include a commercial package offering comprised of general...